Centene Corporation Reports 2015 First Quarter Results And Raises Guidance
-- Revenue increase of 42% and diluted earnings per share (EPS) from continuing operations of $0.52 --

ST. LOUIS, April 28, 2015 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced its financial results for the quarter ended March 31, 2015.  The following discussions, with the exception of cash flow information, are in the context of continuing operations.

Premium and Service Revenues (in millions)

$

4,761

 

Consolidated Health Benefits Ratio

89.8

%

General & Administrative expense ratio

8.5

%

Diluted earnings per share (EPS)

$

0.52

 

Total cash flow from operations (in millions)

$

45

 

Michael F. Neidorff, Centene's Chairman and Chief Executive Officer, stated, "We had a strong start to 2015, delivering exceptional top and bottom line growth compared to last year.  We continue to be successful in executing on our robust growth pipeline while maintaining operational discipline."

First Quarter Highlights

  • March 31, 2015 managed care membership of 4.4 million, an increase of 1.4 million members, or 44% compared to the first quarter of 2014.
  • Premium and service revenues for the first quarter of $4.8 billion, representing 42% growth compared to the first quarter of 2014.
  • Health Benefits Ratio of 89.8% for the first quarter 2015, compared to 89.3% in the first quarter of 2014.
  • General and Administrative expense ratio of 8.5% for the first quarter of 2015, compared to 8.8% in the first quarter of 2014.
  • Operating cash flow of $45 million for the first quarter of 2015.
  • Diluted EPS for the first quarter of 2015 of $0.52, compared to $0.29 in 2014.

Other Events

  • In April 2015, our Indiana subsidiary, Managed Health Services, began operating under an expanded contract with the Indiana Family & Social Services Administration to provide services to its ABD Medicaid enrollees who qualify for the new Hoosier Care Connect Program.
  • In April 2015, Centurion was recommended for an award by the Mississippi Department of Corrections to provide comprehensive correctional healthcare services.  The contract is expected to commence in the third quarter of 2015.
  • In March 2015, we began operating under an expanded STAR+PLUS contract with the Texas Health and Human Service Commission (HHSC) to include nursing facility benefits.  We also began operating under a new contract with the Texas HHSC and the Centers for Medicare and Medicaid Services to serve dual-eligible members in three counties as part of the state's dual demonstration program.
  • In March 2015, our Missouri subsidiary, Home State Health, was selected by the Missouri Division of Purchasing and Materials Management to continue providing managed care services to MO HealthNet Managed Care beneficiaries.  The new contract will be effective in the third quarter of 2015.
  • In February 2015, Superior HealthPlan was tentatively recommended for a contract award by the Texas HHSC to continue to serve STAR Health (Foster Care) Medicaid recipients.  The new STAR Health contract is expected to commence in the third quarter of 2015.

Accreditations & Senior Management Additions

  • In April 2015, we announced the appointment of Marcela Manjarrez Williams to Senior Vice President and Chief Communications Officer and the appointment of Ken Yamaguchi, M.D. to Executive Vice President and Chief Medical Officer.
  • In April 2015, Nurtur, our health and wellness subsidiary, received full Disease Management Accreditation renewal from URAC, a Washington, DC-based healthcare accrediting organization that establishes quality standards for the healthcare industry.  In February 2015, Nurtur also received a three-year Wellness and Health Promotion Accreditation renewal from the National Committee for Quality Assurance (NCQA) for its wellness services.
  • In March 2015, NurseWise, our national multilingual nurse triage and health education subsidiary, also received full Health Call Center Accreditation renewal from URAC.

Membership

The following table sets forth the Company's membership by state for its managed care organizations:

 

March 31,

 

2015

 

2014

Arizona

202,200

 

169,800

Arkansas

43,200

 

16,400

California

171,200

 

118,100

Florida

463,100

 

230,300

Georgia

405,600

 

331,400

Illinois

184,800

 

22,400

Indiana

227,700

 

198,700

Kansas

143,700

 

145,000

Louisiana

359,500

 

149,800

Massachusetts

64,500

 

50,800

Minnesota

9,500

 

9,400

Mississippi

141,900

 

85,400

Missouri

75,600

 

58,100

New Hampshire

67,500

 

37,100

Ohio

296,000

 

181,800

South Carolina

106,000

 

96,300

Tennessee

20,800

 

21,100

Texas

974,900

 

904,000

Vermont

1,600

 

Washington

207,100

 

151,700

Wisconsin

82,100

 

70,800

Total at-risk membership

4,248,500

 

3,048,400

Non-risk membership

153,200

 

Total

4,401,700

 

3,048,400

At March 31, 2015, the Company served 331,800 Medicaid members in Medicaid expansion programs in California, Illinois, Indiana, Massachusetts, New Hampshire, Ohio and Washington included in the table above.

The following table sets forth our membership by line of business:

 

March 31,

 

2015

 

2014

Medicaid

3,133,900

 

2,169,100

CHIP & Foster Care

233,600

 

269,200

ABD, Medicare & Duals

410,400

 

300,500

Long Term Care (LTC)

71,200

 

51,800

Health Insurance Marketplaces

161,700

 

39,700

Hybrid Programs 1

 

14,400

Behavioral Health

195,100

 

162,700

Correctional Healthcare Services

42,600

 

41,000

Total at-risk membership

4,248,500

 

3,048,400

Non-risk membership

153,200

 

Total

4,401,700

 

3,048,400

       

1 In February 2015, hybrid programs in Indiana and Massachusetts were converted to Medicaid expansion contracts.

The following table identifies our dual-eligible membership by line of business.  The membership tables above include these members.

 

March 31,

 

2015

 

2014

ABD

112,600

 

72,800

LTC

52,000

 

41,300

Medicare

6,800

 

6,500

Medicaid / Medicare Duals

12,600

 

Total

184,000

 

120,600

Statement of Operations: Three Months Ended March 31, 2015

  • For the first quarter of 2015, Premium and Service Revenues increased 42% to $4.8 billion from $3.4 billion in the first quarter of 2014.  The increase was a result of a full quarter's impact from expansions or new programs in 2014 in many of our states, particularly Florida, Illinois and Ohio.
  • Consolidated HBR of 89.8% for the first quarter of 2015 represents an increase from 89.3% in the comparable period in 2014 and an increase from 89.3% in the fourth quarter of 2014. The year over year HBR increase is primarily attributable to an increase in higher acuity membership and higher flu related costs over the prior year.
  • The following table compares the results for new business and existing business for the quarters ended March 31:
 

2015

 

2014

Premium and Service Revenue

     

New business

23%

 

20%

Existing business

77%

 

80%

       

HBR

     

New business

91.0%

 

93.1%

Existing business

89.5%

 

88.3%

  • Consolidated G&A expense ratio for the first quarter of 2015 was 8.5%, compared to 8.8% in the prior year.  The year over year decrease in the G&A ratio reflects the leveraging of expenses over higher revenues in 2015 as well as the impact of transaction costs recognized in 2014.  
  • Diluted earnings per share of $0.52 in the first quarter of 2015, compared to $0.29 in 2014.  Diluted earnings per share in 2014 was impacted by $0.11 of net cost associated with the health insurer fee and acquisition transaction costs. 

Balance Sheet and Cash Flow

At March 31, 2015, the Company had cash, investments and restricted deposits of $3.4 billion, including $97 million held by its unregulated entities.  Medical claims liabilities totaled $2.0 billion, representing 45.5 days in claims payable.  Total debt was $1.1 billion, which includes $125 million of borrowings on the $500 million revolving credit facility at quarter end.  Debt to capitalization was 36.6% at March 31, 2015, excluding the $69 million non-recourse mortgage note. 

Cash flow from operations for the three months ended March 31, 2015, was $45 million, or 0.7 times net earnings.  Cash flow was reduced in the first quarter as a result of a one time change in payment terms for one of our states.

A reconciliation of the Company's change in days in claims payable from the immediately preceding quarter-end is presented below:

     

Days in claims payable, December 31, 2014

44.2

 

Timing of claim payments

1.3

 

Days in claims payable, March 31, 2015

45.5

 
     

Outlook

The table below depicts the Company's annual GAAP guidance for 2015.

   

Full Year 2015

 
   

Low

 

High

 

Premium and Service Revenues (in millions)

 

$

20,500

   

$

21,000

   

Diluted EPS

 

$

2.60

   

$

2.72

   

Consolidated Health Benefits Ratio

 

89.2

%

 

89.6

%

 

General & Administrative expense ratio

 

8.0

%

 

8.4

%

 

Effective Tax Rate

 

48.0

%

 

50.0

%

 

Diluted Shares Outstanding (in millions)

 

123.0

   

124.0

   
           

Consistent with our policy, the above table does not include acquisitions that have not yet closed.

Conference Call

As previously announced, the Company will host a conference call Tuesday, April 28, 2015, at 8:30 AM (Eastern Time) to review the financial results for the first quarter ended March 31, 2015, and to discuss its business outlook.  Michael F. Neidorff and William N. Scheffel will host the conference call. 

Investors and other interested parties are invited to listen to the conference call by dialing 1-866-739-7850 in the U.S. and Canada; +1-412-902-6577 from abroad; or via a live, audio webcast on the Company's website at www.centene.com , under the Investors section.  Or, participants can register for the conference call in advance by navigating to http://dpregister.com/10061838 , to receive a dial-in number upon registration.  A webcast replay will be available for on-demand listening shortly after the completion of the call for the next twelve months or until 11:59 PM (Eastern Time) on Tuesday, April 26, 2016, at the aforementioned URL. In addition, a digital audio playback will be available until 9:00 AM Eastern Time on Wednesday, May 6, 2015, by dialing 1-877-344-7529 in the U.S. and Canada, or +1-412-317-0088 from abroad, and entering access code 10061838.

Other Information

The discussion in the third bullet under the heading "Statement of Operations: Three Months Ended March 31, 2015" contains financial information for new and existing businesses.  Existing businesses are primarily state markets or significant geographic expansion in an existing state or product that we have managed for four complete quarters.  New businesses are primarily new state markets or significant geographic expansion in an existing state or product that conversely, we have not managed for four complete quarters.

About Centene Corporation

Centene Corporation, a Fortune 500 company, is a diversified, multi-national healthcare enterprise that provides a portfolio of services to government-sponsored healthcare programs, focusing on under-insured and uninsured individuals.  Many receive benefits provided under Medicaid, including the State Children's Health Insurance Program (CHIP), as well as Aged, Blind or Disabled (ABD), Foster Care and Long Term Care (LTC), in addition to other state-sponsored/hybrid programs, and Medicare (Special Needs Plans).  The Company operates local health plans and offers a range of health insurance solutions.  It also contracts with other healthcare and commercial organizations to provide specialty services including behavioral health management, care management software, correctional healthcare services, dental benefits management, in-home health services, life and health management, managed vision, pharmacy benefits management, specialty pharmacy and telehealth services.

The information provided in this press release contains forward-looking statements that relate to future events and future financial performance of Centene.  Subsequent events and developments may cause the Company's estimates to change.  The Company disclaims any obligation to update this forward-looking financial information in the future.  Readers are cautioned that matters subject to forward-looking statements involve known and unknown risks and uncertainties, including economic, regulatory, competitive and other factors that may cause Centene's or its industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Actual results may differ from projections or estimates due to a variety of important factors, including Centene's ability to accurately predict and effectively manage health benefits and other operating expenses and reserves; competition; membership and revenue projections; timing of regulatory contract approval; changes in healthcare practices; changes in federal or state laws or regulations, including the Patient Protection and Affordable Care Act and the Health Care and Education Affordability Reconciliation Act and any regulations enacted thereunder; changes in expected contract start dates; changes in expected closing dates, estimated purchase price and accretion for acquisitions; inflation; foreign currency fluctuations; provider and state contract changes; new technologies; advances in medicine; reduction in provider payments by governmental payors; major epidemics; disasters and numerous other factors affecting the delivery and cost of healthcare; the expiration, cancellation or suspension of our Medicare or Medicaid managed care contracts by federal or state governments; the outcome of pending legal proceedings; availability of debt and equity financing, on terms that are favorable to us; and general economic and market conditions, as well as those factors disclosed in the Company's publicly filed documents.

This list of important factors is not intended to be exhaustive. We discuss certain of these matters more fully, as well as certain risk factors that may affect our business operations, financial condition and results of operations, in our filings with the Securities and Exchange Commission, including our annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K.

 [Tables Follow]

 

CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In millions except share data)
(Unaudited)

       
 

March 31, 2015

 

December 31, 2014

ASSETS

     

Current assets:

     

Cash and cash equivalents

$

1,666

 

$

1,610

Premium and related receivables

1,245

 

912

Short term investments

151

 

177

Other current assets

528

 

335

Total current assets

3,590

 

3,034

Long term investments

1,527

 

1,280

Restricted deposits

98

 

100

Property, software and equipment, net

450

 

445

Goodwill

786

 

754

Intangible assets, net

131

 

120

Other long term assets

114

 

91

Total assets

$

6,696

 

$

5,824

       

LIABILITIES AND STOCKHOLDERS' EQUITY

     

Current liabilities:

     

Medical claims liability

$

1,950

 

$

1,723

Accounts payable and accrued expenses

1,002

 

768

Return of premium payable

269

 

236

Unearned revenue

117

 

168

Current portion of long term debt

5

 

5

Total current liabilities

3,343

 

2,900

Long term debt

1,123

 

874

Other long term liabilities

238

 

159

Total liabilities

4,704

 

3,933

Commitments and contingencies

     

Redeemable noncontrolling interests

155

 

148

Stockholders' equity:

     

Preferred stock, $0.001 par value; authorized 10,000,000 shares; no shares issued or outstanding at March 31, 2015 and December 31, 2014

 

Common stock, $.001 par value; authorized 200,000,000 shares; 124,562,959 issued and 118,886,912 outstanding at March 31, 2015, and 124,274,864 issued and 118,433,416 outstanding at December 31, 2014

 

Additional paid-in capital

870

 

840

Accumulated other comprehensive loss

(1)

 

(1)

Retained earnings

1,066

 

1,003

Treasury stock, at cost (5,676,047 and 5,841,448 shares, respectively)

(98)

 

(98)

Total Centene stockholders' equity

1,837

 

1,744

Noncontrolling interest

 

(1)

Total stockholders' equity

1,837

 

1,743

Total liabilities and stockholders' equity

$

6,696

 

$

5,824

 

CENTENE CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(In millions, except share data)
(Unaudited)

   
 

Three Months Ended March 31,

 

2015

 

2014

Revenues:

     

Premium

$

4,299

 

$

3,071

Service

462

 

281

Premium and service revenues

4,761

 

3,352

Premium tax and health insurer fee

370

 

108

Total revenues

5,131

 

3,460

Expenses:

     

Medical costs

3,861

 

2,743

Cost of services

402

 

242

General and administrative expenses

403

 

296

Premium tax expense

281

 

78

Health insurer fee expense

55

 

31

Total operating expenses

5,002

 

3,390

Earnings from operations

129

 

70

Other income (expense):

     

Investment and other income

9

 

5

Interest expense

(10)

 

(7)

Earnings from continuing operations, before income tax expense

128

 

68

Income tax expense

63

 

35

Earnings from continuing operations, net of income tax expense

65

 

33

Discontinued operations, net of income tax expense o f $0 and $0, respectively

(1)

 

(1)

Net earnings

64

 

32

(Earnings) loss attributable to noncontrolling interests

(1)

 

1

Net earnings attributable to Centene Corporation

$

63

 

$

33

       

Amounts attributable to Centene Corporation common shareholders:

             

Earnings from continuing operations, net of income tax expense

$

64

 

$

34

Discontinued operations, net of income tax expense (benefit)

(1)

 

(1)

Net earnings

$

63

 

$

33

       

Net earnings (loss) per common share attributable to Centene Corporation:

             

Basic:

     

Continuing operations

$

0.54

 

$

0.30

Discontinued operations

(0.01)

 

(0.01)

Basic earnings per common share

$

0.53

 

$

0.29

       

Diluted:

     

Continuing operations

$

0.52

 

$

0.29

Discontinued operations

(0.01)

 

(0.01)

Diluted earnings per common share

$

0.51

 

$

0.28

       

Weighted average number of common shares outstanding:

             

Basic

118,783,755

 

114,967,752

Diluted

122,572,366

 

118,722,532

 

CENTENE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)

(Unaudited)

   
 

Three Months Ended March 31,

 

2015

 

2014

Cash flows from operating activities:

     

Net earnings

$

64

   

$

32

 

Adjustments to reconcile net earnings to net cash provided by operating activities

             

Depreciation and amortization

27

   

20

 

Stock compensation expense

16

   

11

 

Deferred income taxes

(6)

   

(8)

 

Gain on settlement of contingent consideration

(10)

   

 

Changes in assets and liabilities

     

Premium and related receivables

(334)

   

(119)

 

Other current assets

(3)

   

3

 

Other assets

(13)

   

(14)

 

Medical claims liabilities

227

   

196

 

Unearned revenue

(51)

   

35

 

Accounts payable and accrued expenses

58

   

91

 

Other long term liabilities

68

   

4

 

Other operating activities

2

   

1

 

Net cash provided by operating activities

45

   

252

 

Cash flows from investing activities:

     

Capital expenditures

(27)

   

(18)

 

Purchases of investments

(307)

   

(167)

 

Sales and maturities of investments

111

   

112

 

Proceeds from asset sale

7

   

 

Investments in acquisitions, net of cash acquired

(9)

   

(77)

 

Net cash used in investing activities

(225)

   

(150)

 

Cash flows from financing activities:

     

Proceeds from exercise of stock options

2

   

2

 

Proceeds from borrowings

500

   

645

 

Payment of long term debt

(253)

   

(519)

 

Excess tax benefits from stock compensation

3

   

 

Common stock repurchases

(4)

   

(2)

 

Contribution from noncontrolling interest

   

5

 

Debt issue costs

(4)

   

 

Payment of contingent consideration obligation

(8)

   

 

Net cash provided by financing activities

236

   

131

 

Net increase in cash and cash equivalents

56

   

233

 

Cash and cash equivalents, beginning of period

1,610

   

1,038

 

Cash and cash equivalents, end of period

$

1,666

   

$

1,271

 

Supplemental disclosures of cash flow information:

     

Interest paid

$

2

   

$

2

 

Income taxes paid

$

24

   

$

21

 

Equity issued in connection with acquisitions

$

13

   

$

132

 

 

CENTENE CORPORATION
SUPPLEMENTAL FINANCIAL DATA FROM CONTINUING OPERATIONS

                   
 

Q1

 

Q4

 

Q3

 

Q2

 

Q1

 

2015

 

2014

 

2014

 

2014

 

2014

MANAGED CARE MEMBERSHIP

                 

Arizona

202,200

   

204,000

   

202,500

   

189,200

   

169,800

 

Arkansas

43,200

   

38,400

   

36,600

   

31,100

   

16,400

 

California

171,200

   

163,900

   

144,700

   

131,100

   

118,100

 

Florida

463,100

   

425,700

   

411,200

   

313,800

   

230,300

 

Georgia

405,600

   

389,100

   

382,600

   

373,000

   

331,400

 

Illinois

184,800

   

87,800

   

31,300

   

29,500

   

22,400

 

Indiana

227,700

   

197,700

   

199,500

   

200,500

   

198,700

 

Kansas

143,700

   

143,300

   

144,200

   

146,100

   

145,000

 

Louisiana

359,500

   

152,900

   

150,800

   

148,600

   

149,800

 

Massachusetts

64,500

   

48,400

   

46,600

   

47,200

   

50,800

 

Minnesota

9,500

   

9,500

   

9,500

   

9,400

   

9,400

 

Mississippi

141,900

   

108,700

   

99,300

   

97,400

   

85,400

 

Missouri

75,600

   

71,000

   

64,900

   

58,700

   

58,100

 

New Hampshire

67,500

   

62,700

   

56,600

   

39,500

   

37,100

 

Ohio

296,000

   

280,100

   

261,000

   

225,900

   

181,800

 

South Carolina

106,000

   

109,700

   

106,500

   

101,800

   

96,300

 

Tennessee

20,800

   

21,000

   

21,200

   

21,300

   

21,100

 

Texas

974,900

   

971,000

   

961,100

   

921,500

   

904,000

 

Vermont

1,600

   

   

   

   

 

Washington

207,100

   

194,400

   

192,500

   

193,800

   

151,700

 

Wisconsin

82,100

   

83,200

   

74,700

   

67,300

   

70,800

 

Total at-risk membership

4,248,500

   

3,762,500

   

3,597,300

   

3,346,700

   

3,048,400

 

Non-risk membership

153,200

   

298,400

   

303,500

   

   

 

TOTAL

4,401,700

   

4,060,900

   

3,900,800

   

3,346,700

   

3,048,400

 
                   

Medicaid

3,133,900

   

2,754,900

   

2,578,300

   

2,385,500

   

2,169,100

 

CHIP & Foster Care

233,600

   

222,700

   

247,700

   

261,800

   

269,200

 

ABD, Medicare & Duals

410,400

   

392,700

   

383,400

   

329,700

   

300,500

 

LTC

71,200

   

60,800

   

55,200

   

53,500

   

51,800

 

Health Insurance Marketplaces

161,700

   

74,500

   

76,000

   

75,700

   

39,700

 

Hybrid Programs

   

18,900

   

19,900

   

17,000

   

14,400

 

Behavorial Health

195,100

   

197,000

   

195,500

   

182,200

   

162,700

 

Correctional Healthcare Services

42,600

   

41,000

   

41,300

   

41,300

   

41,000

 

Total at-risk membership

4,248,500

   

3,762,500

   

3,597,300

   

3,346,700

   

3,048,400

 

Non-risk membership

153,200

   

298,400

   

303,500

   

   

 

TOTAL

4,401,700

   

4,060,900

   

3,900,800

   

3,346,700

   

3,048,400

 
                   
                   

REVENUE PER MEMBER PER MONTH(a)

$

349

   

$

360

   

$

354

   

$

344

   

$

340

 
                   

CLAIMS(a)

                 

Period-end inventory

1,217,000

   

1,086,600

   

1,021,200

   

771,900

   

832,600

 

Average inventory

841,000

   

806,000

   

660,200

   

603,700

   

584,700

 

Period-end inventory per member

0.29

   

0.29

   

0.28

   

0.23

   

0.27

 
 

(a) Revenue per member and claims information are presented for the Managed Care at-risk members.

                   

NUMBER OF EMPLOYEES

14,800

   

13,400

   

12,900

   

12,300

   

11,200

 
                                       

 

 

Q1

 

Q4

 

Q3

 

Q2

 

Q1

 

2015

 

2014

 

2014

 

2014

 

2014

                   

DAYS IN CLAIMS PAYABLE (b)

45.5

   

44.2

   

43.1

   

42.9

   

42.6

 
 

(b) Days in Claims Payable is a calculation of Medical Claims Liabilities at the end of the period divided by average claims expense per calendar day for such period.

                   

CASH, INVESTMENTS AND RESTRICTED DEPOSITS (in millions)

Regulated

$

3,345

   

$

3,082

   

$

2,829

   

$

2,353

   

$

2,167

 

Unregulated

97

   

85

   

70

   

50

   

49

 

TOTAL

$

3,442

   

$

3,167

   

$

2,899

   

$

2,403

   

$

2,216

 
                   

DEBT TO CAPITALIZATION

38.0

%

 

33.5

%

 

36.4

%

 

35.3

%

 

36.2

%

DEBT TO CAPITALIZATION EXCLUDING NON-RECOURSE DEBT(c)

36.6

%

 

31.7

%

 

34.6

%

 

33.4

%

 

34.1

%

 

(c) The non-recourse debt represents the Company's mortgage note payable ($69 million at March 31, 2015).

Debt to Capitalization is calculated as follows: total debt divided by (total debt + total equity).

 

Operating Ratios:

   
 

Three Months Ended March 31,

 

2015

 

2014

Health Benefits Ratios:

     

Medicaid, CHIP, Foster Care & Health Insurance Marketplaces

87.6

%

 

86.9

%

ABD, LTC & Medicare

92.9

   

92.9

 

Specialty Services

85.2

   

87.7

 

  Total

89.8

   

89.3

 
       

Total General & Administrative Expense Ratio

8.5

%

 

8.8

%

 

MEDICAL CLAIMS LIABILITY (In millions)

         

The changes in medical claims liability are summarized as follows:

         

Balance, March 31, 2014

 

$

1,299

 

Incurred related to:

   

Current period

 

13,981

 

Prior period

 

(185)

 

Total incurred

 

13,796

 

Paid related to:

   

Current period

 

12,072

 

Prior period

 

1,073

 

Total paid

 

13,145

 

Balance, March 31, 2015

 

$

1,950

 

Centene's claims reserving process utilizes a consistent actuarial methodology to estimate Centene's ultimate liability.  Any reduction in the "Incurred related to: Prior period" amount may be offset as Centene actuarially determines "Incurred related to: Current period."  As such, only in the absence of a consistent reserving methodology would favorable development of prior period claims liability estimates reduce medical costs.  Centene believes it has consistently applied its claims reserving methodology in each of the periods presented.  Additionally, as a result of minimum HBR and other state return of premium programs, approximately $60 million of the "Incurred related to: Prior period" was reclassified to Return of Premium Payable.

The amount of the "Incurred related to: Prior period" above represents favorable development and includes the effects of reserving under moderately adverse conditions, new markets where we use a conservative approach in setting reserves during the initial periods of operations, receipts from other third party payors related to coordination of benefits and lower medical utilization and cost trends for dates of service prior to March 31, 2014. 

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/centene-corporation-reports-2015-first-quarter-results-and-raises-guidance-300072946.html

SOURCE Centene Corporation